UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes

Blood, 2023-04, Vol.141 (14), p.1768-1772

2023

Volltextzugriff (PDF)

Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response

Journal of internal medicine, 2024-02, Vol.295 (2), p.229-241

2024

Volltextzugriff (PDF)

Advances in the treatment of Hodgkin lymphoma: Current and future approaches

Frontiers in oncology, 2023-03, Vol.13, p.1067289-1067289

2023

Volltextzugriff (PDF)

Molecular patterns identify distinct subclasses of myeloid neoplasia

Nature communications, 2023-05, Vol.14 (1), p.3136-3136, Article 3136

2023

Volltextzugriff (PDF)

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Nature communications, 2024-02, Vol.15 (1), p.1184-1184, Article 1184

2024

Volltextzugriff (PDF)

Clinical and molecular characteristics of extramedullary acute myeloid leukemias

Leukemia, 2024-07

2024

Volltextzugriff (PDF)

Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria

British journal of haematology, 2024-05, Vol.204 (5), p.2121-2124

2024

Volltextzugriff (PDF)

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Journal of hematology and oncology, 2023-08, Vol.16 (1), p.91-91, Article 91

2023

Volltextzugriff (PDF)

New approaches to idiopathic neutropenia in the era of clonal hematopoiesis

Experimental hematology & oncology, 2023-04, Vol.12 (1), p.42-42, Article 42

2023

Volltextzugriff (PDF)

Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment

Cancers, 2024-04, Vol.16 (7), p.1307

2024

Volltextzugriff (PDF)

Single-Cell Next-Generation Sequencing to Monitor Hematopoietic Stem-Cell Transplantation: Current Applications and Future Perspectives

Cancers, 2023-04, Vol.15 (9), p.2477

2023

Volltextzugriff (PDF)

Real‐world outcomes of patients with resected stage III melanoma treated with adjuvant therapies

Cancer medicine (Malden, MA), 2024-06, Vol.13 (12), p.e7257-n/a

2024

Volltextzugriff (PDF)

Immune-related hypophysitis: An analysis of a heterogeneous entity

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14704-e14704

2023

Volltextzugriff (PDF)

Impact of BAP1 mutational status on immunotherapy outcomes in advanced malignant pleural mesothelioma: A single institution experience

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e20537-e20537

2023

Volltextzugriff (PDF)

Prognostic impact of immune-related adverse events on survival outcomes in metastatic gastrointestinal cancer: A single-institutional experience

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.801-801

2023

Volltextzugriff (PDF)

Real world outcome of neuroendocrine carcinomas of the bladder compared to conventional tumors of the bladder

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16591-e16591

2023

Volltextzugriff (PDF)

Longitudinal trends in serum calcium, parathormone and bone mineral density in breast cancer survivors on aromatase inhibitor therapy: A single institutional cohort study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12531-e12531

2023

Volltextzugriff (PDF)

Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes

Translational andrology and urology, 2022-06, Vol.11 (6), p.877-901

2022

Volltextzugriff (PDF)

Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia

Blood, 2022-11, Vol.140 (Supplement 1), p.5795-5796

2022

Volltextzugriff (PDF)

New Approaches to Chronic Idiopathic Neutropenia in the Era of Clonal Hematopoiesis

Blood, 2022-11, Vol.140 (Supplement 1), p.2916-2917

2022

Volltextzugriff (PDF)

Splicing Analysis Unveils Convergent Transcriptomic Pathways in U2AF1 S34 and Q157 Mutant Myeloid Neoplasia

Blood, 2022-11, Vol.140 (Supplement 1), p.6890-6891

2022

Volltextzugriff (PDF)

Splenectomy for Immune Cytopenias: Treatment Outcomes and Predictors of Response

Blood, 2022-11, Vol.140 (Supplement 1), p.1226-1227

2022

Volltextzugriff (PDF)

Hemolytic versus malproductive anemia in large granular lymphocytic leukemia

Leukemia, 2024-08, Vol.38 (8), p.1839-1842

2024

Volltextzugriff (PDF)

Immunotherapy versus targeted therapy in the adjuvant setting for resected stage III melanoma: A single institution study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21578-e21578

2022

Volltextzugriff (PDF)

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndrome

Blood, 2022-11, Vol.140 (Supplement 1), p.6942-6944

2022

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes

Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response

Advances in the treatment of Hodgkin lymphoma: Current and future approaches

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Clinical and molecular characteristics of extramedullary acute myeloid leukemias

Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

New approaches to idiopathic neutropenia in the era of clonal hematopoiesis

Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment

Single-Cell Next-Generation Sequencing to Monitor Hematopoietic Stem-Cell Transplantation: Current Applications and Future Perspectives

Real‐world outcomes of patients with resected stage III melanoma treated with adjuvant therapies

Immune-related hypophysitis: An analysis of a heterogeneous entity

Impact of BAP1 mutational status on immunotherapy outcomes in advanced malignant pleural mesothelioma: A single institution experience

Prognostic impact of immune-related adverse events on survival outcomes in metastatic gastrointestinal cancer: A single-institutional experience

Real world outcome of neuroendocrine carcinomas of the bladder compared to conventional tumors of the bladder

Longitudinal trends in serum calcium, parathormone and bone mineral density in breast cancer survivors on aromatase inhibitor therapy: A single institutional cohort study

Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes

Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia

New Approaches to Chronic Idiopathic Neutropenia in the Era of Clonal Hematopoiesis

Splicing Analysis Unveils Convergent Transcriptomic Pathways in U2AF1 S34 and Q157 Mutant Myeloid Neoplasia

Splenectomy for Immune Cytopenias: Treatment Outcomes and Predictors of Response

Hemolytic versus malproductive anemia in large granular lymphocytic leukemia

Immunotherapy versus targeted therapy in the adjuvant setting for resected stage III melanoma: A single institution study

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndrome

Suchergebnisse filtern